Search Results
Anagrelide 50 mg | 100.00%
TargetMol

Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. The physiologic effect of anagrelide is by means of Decreased Platelet Production.
More Information Supplier PageAnagrelide 25 mg | 100.00%
TargetMol

Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. The physiologic effect of anagrelide is by means of Decreased Platelet Production.
More Information Supplier PageAnagrelide 10 mg | 100.00%
TargetMol

Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. The physiologic effect of anagrelide is by means of Decreased Platelet Production.
More Information Supplier PageRocuronium bromide 50 mg | 100.00%
TargetMol

Rocuronium bromide (ORG 9426) is a muscle relaxant or aminosteroid non-depolarizing neuromuscular blocker. During surgery or mechanical ventilation, it is used to facilitate endotracheal intubation and to provide skeletal muscle relaxation.
More Information Supplier PageOxaliplatin 200 mg | 99.93%
TargetMol
Oxaliplatin 50 mg | 99.93%
TargetMol
Urapidil 100 mg | Purity Not Available
TargetMol

Urapidil, a sympatholytic antihypertensive drug, acts as a 5-HT1A receptor agonist and as an α1-adrenoceptor antagonist.
More Information Supplier PageUrapidil 50 mg | Purity Not Available
TargetMol

Urapidil, a sympatholytic antihypertensive drug, acts as a 5-HT1A receptor agonist and as an α1-adrenoceptor antagonist.
More Information Supplier PageVinpocetine 100 mg | 100.00%
TargetMol

Vinpocetine is a selective inhibitor of cyclic GMP phosphodiesterase (PDE).
More Information Supplier Page